Idioma: Inglés
Publicado por CreateSpace Independent Publishing Platform, 2013
ISBN 10: 149050057X ISBN 13: 9781490500577
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 14,05
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Idioma: Inglés
Publicado por CreateSpace Independent Publishing Platform, 2013
ISBN 10: 149050057X ISBN 13: 9781490500577
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 20,39
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Idioma: Inglés
Publicado por CreateSpace Independent Publishing Platform, 2013
ISBN 10: 149050057X ISBN 13: 9781490500577
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 23,55
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por CreateSpace Independent Publishing Platform, 2013
ISBN 10: 149050057X ISBN 13: 9781490500577
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 55,95
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por Createspace Independent Publishing Platform, 2013
ISBN 10: 149050057X ISBN 13: 9781490500577
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
EUR 39,78
Cantidad disponible: Más de 20 disponibles
Añadir al carritoPaperback / softback. Condición: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.
Idioma: Inglés
Publicado por Createspace Independent Publishing Platform, 2013
ISBN 10: 149050057X ISBN 13: 9781490500577
Librería: CitiRetail, Stevenage, Reino Unido
EUR 23,56
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. The purpose of the "Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7)" is to provide an evidence-based approach to the prevention and management of hypertension. The key messages of this report are: in those older than age 50, systolic blood pressure (SBP) of greater than 140 mmHg is a more important cardiovascular disease (CVD) risk factor than diastolic BP (DBP); beginning at 115/75 mmHg, CVD risk doubles for each increment of 20/10 mmHg; those who are normotensive at 55 years of age will have a 90 percent lifetime risk of developing hypertension; prehypertensive individuals (SBP 120-139 mmHg or DBP 80-89 mmHg) require health promoting lifestyle modifications to prevent the progressive rise in blood pressure and CVD; for uncomplicated hypertension, thiazide diuretic should be used in drug treatment for most, either alone or combined with drugs from other classes; this report delineates specific high-risk conditions, which are compelling indications for the use of other antihypertensive drug classes (angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, beta blockers, calcium channel blockers); two or more antihypertensive medications will be required to achieve goal BP (less than 140/90 mmHg, or less than 130/80 mmHg for patients with diabetes and chronic kidney disease); for patients whose BP is greater than 20 mmHg above the SBP goal or 10 mmHg above the DBP goal, initiation of therapy using two agents, one of which usually will be a thiazide diuretic, should be considered; regardless of therapy or care, hypertension will only be controlled if patients are motivated to stay on their treatment plan. Positive experiences, trust in the clinician, and empathy improve patient motivation and satisfaction. This report serves as a guide, and the committee continues to recognize that the responsible physician's judgment remains paramount. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.